These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20214298)

  • 21. [Treatment strategy for chronic hepatitis C in Japan].
    Arase Y; Kumada H
    Nihon Rinsho; 2011 May; 69 Suppl 4():180-4. PubMed ID: 22096915
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effectiveness of long-acting interferon (peginterferon)].
    Kondo Y; Tateishi R; Yoshida H; Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):515-8. PubMed ID: 15359853
    [No Abstract]   [Full Text] [Related]  

  • 23. [Two-step interferon rebound therapy].
    Kato M; Yuki N; Iyoda K; Yamamoto K; Hayashi N
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):497-501. PubMed ID: 15359849
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination treatment for chronic HCV hepatitis in lymphangioleiomyomatosis: first case report.
    Bartalesi F; Camiciottoli G; Corti G; Maluccio NM; Biliotti E; Bartoloni A; Taliani G
    J Chemother; 2009 Feb; 21(1):110-1. PubMed ID: 19297285
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hepatitis C: 15 years of life].
    Perez V
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S9-10. PubMed ID: 20214283
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hepatitis C infection. Overweight virus carriers are more difficult to cure].
    MMW Fortschr Med; 2004 Mar; 146(13):58. PubMed ID: 15219135
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of elderly patients with chronic hepatitis C].
    Ikeda F; Yamamoto K; Iwasaki Y
    Nihon Rinsho; 2011 May; 69 Suppl 4():221-6. PubMed ID: 22096923
    [No Abstract]   [Full Text] [Related]  

  • 28. [Anti-viral therapy of type C chronic hepatitis. 3. New development in anti-viral therapy of type C chronic hepatitis--Peg-IFN/ribavirin combination therapy and a new anti-viral treatment].
    Hiramatsu N
    Nihon Naika Gakkai Zasshi; 2008 Jan; 97(1):75-81. PubMed ID: 18360974
    [No Abstract]   [Full Text] [Related]  

  • 29. [Healing of chronic hepatitis C following 12 weeks of therapy with peginterferon-alpha and ribavirin].
    Barreales M; Castellano G; Fernández I; Muñoz R; Manzano M; Solís Herruzo JA
    Rev Esp Enferm Dig; 2007 Dec; 99(12):738-40. PubMed ID: 18290706
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment for chronic hepatitis C.
    Bacon BR
    Curr Gastroenterol Rep; 2003 Feb; 5(1):1-2. PubMed ID: 12530942
    [No Abstract]   [Full Text] [Related]  

  • 31. Extending combination therapy with peginterferon alfa-2b plus ribavirin for genotype 1 chronic hepatitis C late responders: a report of 9 cases.
    Buti M; Valdés A; Sánchez-Avila F; Esteban R; Lurie Y
    Hepatology; 2003 May; 37(5):1226-7. PubMed ID: 12717407
    [No Abstract]   [Full Text] [Related]  

  • 32. Metformin, hepatitis C, and insulin resistance: sufficient evidence?
    Yilmaz Y; Yonal O; Imeryuz N
    Hepatology; 2009 Dec; 50(6):2054-5; author reply 2055. PubMed ID: 19937685
    [No Abstract]   [Full Text] [Related]  

  • 33. [High dose repeat therapy in previously treated patients with chronic hepatitis C].
    Hoepffner N; Paul KA; Nikodem AB; Teuber G
    Dtsch Med Wochenschr; 2006 Mar; 131(11):543-4. PubMed ID: 16538557
    [No Abstract]   [Full Text] [Related]  

  • 34. ADVANCE study begins enrollment.
    AIDS Patient Care STDS; 2008 Apr; 22(4):345. PubMed ID: 18422463
    [No Abstract]   [Full Text] [Related]  

  • 35. Peginterferon Alfa-2b and ribavirin for 12 versus 24 weeks in HCV infection.
    Henry MJ
    N Engl J Med; 2005 Sep; 353(11):1182-3; author reply 1182-3. PubMed ID: 16167381
    [No Abstract]   [Full Text] [Related]  

  • 36. Peginterferon alfa-2b plus ribavirin for chronic hepatitis.
    Cecil BD
    Lancet; 2002 Jan; 359(9302):263-4. PubMed ID: 11812598
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antiviral therapy for chronic viral hepatitis B and C].
    Iino S
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():787-91. PubMed ID: 12722317
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis C treatment: interferon free or interferon freer?
    Dusheiko G; Burney T
    Lancet; 2013 Jun; 381(9883):2063-5. PubMed ID: 23499437
    [No Abstract]   [Full Text] [Related]  

  • 39. Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV.
    Liu CH; Chen DS; Kao JH
    N Engl J Med; 2007 Oct; 357(16):1661; author reply 1661-2. PubMed ID: 17948345
    [No Abstract]   [Full Text] [Related]  

  • 40. PEG-IFN, RBV dosing during chronic HCV re-treatment.
    Highleyman L
    IAPAC Mon; 2007 Feb; 13(2):55. PubMed ID: 17948601
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.